Graf Akcie CORT (Corcept Therapeutics Inc). Diskuze k akciím CORT. Aktuální informace CORT.

Základní informace o společnosti Corcept Therapeutics Inc (Akcie CORT)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 2.34B
Hodnota podniku (EV) 1.98B
Tržby 343.087M
EBITDA 110.184M
Zisk 97.607M
Růst v tržbách Q/Q 3.41 %
Růst v tržbách Y/Y -2.31 %
P/E (Cena vůči ziskům) 23.86
Forward P/E N/A
EV/Sales 5.76
EV/EBITDA 17.95
EV/EBIT 18.51
PEG N/A
Price/Sales 6.81
P/FCF 17.46
Price/Book 4.47
Účetní hodnota na akcii 4.49
Hotovost na akcii 3.78
FCF vůči ceně 5.73 %
Počet zaměstnanců 236
Tržba na zaměstnance 1454000
Profit margin 29.96 %
Operating margin 31.13 %
Gross margin 98.42 %
EBIT margin 31.13 %
EBITDA margin 32.12 %
EPS - Zisk na akcii 0.84
EPS - Kvartální růst -8.70 %
EPS - Očekávaný růst příští rok 17.65 %
Return on assets 17.53 %
Return on equity 19.08 %
ROIC 26.06 %
ROCE 20.42 %
Dluhy/Equity 0.09
Čistý dluh/EBITDA -14.55
Current ratio 9.06
Quick Ratio 8.63
Volatilita 3.06
Beta 0.72
RSI 44.62
Cílová cena analytiků 22
Známka akcie (dle analytiků) 2.25
Insider ownership 9.91 %
Institutional ownership 72.00 %
Počet akcií 115.927M
Procento shortovaných akcií 10.90 %
Short ratio 20.13 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 1982
Země United States

Finanční výsledky akcie CORT

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$353.874$306.486$251.247$159.201$81.321$50.286
Cost Of Goods Sold$5.582$5.504$5.215$3.554$2.058$1.361
Gross Profit$348.292$300.982$246.032$155.647$79.263$48.925
Research And Development Expenses$114.764$89.017$75.247$40.376$23.844$15.419
SG&A Expenses$105.326$100.359$81.289$62.416$45.24$36.949
Other Operating Income Or Expenses------
Operating Expenses$225.672$194.88$161.751$106.346$71.142$53.729
Operating Income$128.202$111.606$89.496$52.855$10.179$-3.443
Total Non-Operating Income/Expense$3.4$5.07$2.657$-0.049$-2.039$-2.965
Pre-Tax Income$131.602$116.676$92.153$52.806$8.14$-6.408
Income Taxes$25.591$22.495$16.743$-76.316--
Income After Taxes$106.011$94.181$75.41$129.122$8.14$-6.408
Other Income------
Income From Continuous Operations$106.011$94.181$75.41$129.122$8.14$-6.408
Income From Discontinued Operations------
Net Income$106.011$94.181$75.41$129.122$8.14$-6.408
EBITDA$131.742$112.039$88.011$52.975$10.287$-3.266
EBIT$128.202$111.606$89.496$52.855$10.179$-3.443
Basic Shares Outstanding115114115114111107
Shares Outstanding124123127125116107
Basic EPS$0.92$0.82$0.65$1.14$0.07$-0.06
EPS - Earnings Per Share$0.85$0.77$0.60$1.04$0.07$-0.06
# 2020 2019 2018 2017 2016 2015
Current Ratio10.0757.91326.65734.19982.39972.3462
Long-term Debt / Capital-----0.4038
Debt/Equity Ratio----0.35441.4863
Gross Margin98.422698.204297.924497.767697.469397.2935
Operating Margin36.228236.414735.620733.200212.5171-6.8468
EBIT Margin36.228236.414735.620733.200212.5171-6.8468
EBITDA Margin37.228536.55635.029733.275512.6499-6.4949
Pre-Tax Profit Margin37.18938.06936.678333.169410.0097-12.7431
Net Profit Margin29.957330.729330.014381.106310.0097-12.7431
Asset Turnover0.6190.74330.80610.72191.18280.9689
Inventory Turnover Ratio1.13691.01471.10210.77670.88360.8092
Receiveable Turnover13.507715.379714.28515.64628.24768.0833
Days Sales In Receivables27.021723.732625.55164.644944.255545.155
ROE - Return On Equity20.256725.373327.334267.614519.6718-34.6416
Return On Tangible Equity20.256725.373327.334267.614519.6718-34.6416
ROA - Return On Assets18.542122.842224.193658.548911.8395-12.3463
ROI - Return On Investment20.256725.373327.334267.614519.6718-20.6537
Book Value Per Share4.48313.24042.39831.66470.36710.1687
Operating Cash Flow Per Share0.11310.19760.42360.3310.12910.3004
Free Cash Flow Per Share0.1120.19110.42460.32930.12760.3019